These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16365196)

  • 1. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
    Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
    Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic.
    Lutgens SP; Kisters N; Lutgens E; van Haaften RI; Evelo CT; de Winther MP; Saftig P; Daemen MJ; Heeneman S; Cleutjens KB
    J Pathol; 2006 Nov; 210(3):334-43. PubMed ID: 16972305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice.
    Guo J; Bot I; de Nooijer R; Hoffman SJ; Stroup GB; Biessen EA; Benson GM; Groot PH; Van Eck M; Van Berkel TJ
    Cardiovasc Res; 2009 Feb; 81(2):278-85. PubMed ID: 19015136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro.
    Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
    de Nooijer R; Bot I; von der Thüsen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of hedgehog signalling in ApoE - /- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages.
    Beckers L; Heeneman S; Wang L; Burkly LC; Rousch MM; Davidson NO; Gijbels MJ; de Winther MP; Daemen MJ; Lutgens E
    J Pathol; 2007 Aug; 212(4):420-8. PubMed ID: 17573667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
    Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
    J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques.
    Tsukano H; Gotoh T; Endo M; Miyata K; Tazume H; Kadomatsu T; Yano M; Iwawaki T; Kohno K; Araki K; Mizuta H; Oike Y
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1925-32. PubMed ID: 20651282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K; Yao W; Zheng X; Liao K
    Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.
    Ricci R; Sumara G; Sumara I; Rozenberg I; Kurrer M; Akhmedov A; Hersberger M; Eriksson U; Eberli FR; Becher B; Borén J; Chen M; Cybulsky MI; Moore KJ; Freeman MW; Wagner EF; Matter CM; Lüscher TF
    Science; 2004 Nov; 306(5701):1558-61. PubMed ID: 15567863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development.
    Agrawal S; Febbraio M; Podrez E; Cathcart MK; Stark GR; Chisolm GM
    Circulation; 2007 Jun; 115(23):2939-47. PubMed ID: 17533179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destabilizing role of cathepsin S in murine atherosclerotic plaques.
    Rodgers KJ; Watkins DJ; Miller AL; Chan PY; Karanam S; Brissette WH; Long CJ; Jackson CL
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):851-6. PubMed ID: 16410454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
    Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
    Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
    Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis.
    Yamada S; Ding Y; Tanimoto A; Wang KY; Guo X; Li Z; Tasaki T; Nabesima A; Murata Y; Shimajiri S; Kohno K; Ichijo H; Sasaguri Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1555-64. PubMed ID: 21527753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.